童康片辅助治疗儿童咳嗽变异性哮喘的临床观察

Efficacy of Tongkang Tablets for Cough Variant Asthma in Children: A Clinical Observation

目的:分析儿童咳嗽变异性哮喘(CVA)的临床特点,观察童康片辅助治疗儿童CVA的疗效。方法:将96例CVA患儿以随机抽样法分为对照组48例和治疗组48例。对照组患儿给予口服西替利嗪糖浆和氨茶碱片,治疗组患儿在对照组的基础上加用童康片,疗程均为8周,并随访3个月,观察各组患儿复发情况。结果:2组总有效率及复发率比较,差异均有统计学意义(P<0.05)。结论:童康片辅助治疗儿童CVA,疗效佳,复发率低,无明显副作用。

OBJECTIVE ： To analyze the clinical features of children cough variant asthma （CVA） and investigate the curative efficacy of Tongkang Tablets as an adjuvant therapy for CVA. METHODS： 96 children with CVA were randomly assigned to two groups （control group vs. experimental group） of 48 each. The control group was treated with cetirizine syrup plus aminophylline tablets for 8 weeks, while the experiment group was treated with add-on Tongkang Tablets for 8 weeks. The recurrence rates of disease in the two groups were followed up for 3 months. RESULTS： There were statistically significant differences between the two groups in terms of total response rate and recurrence rate （P 〈 0. 05）. CONCLUSION： Treatment of CVA children with add-on Tongkang Tablets resulted in satisfactory curative efficacy, low recurrence of disease and few side effects.